Cobas ASY schedule 66 III clinical analyzers for medical treatment facility

Ended Awarded

Contract number
HT009026FL046
Awardee
Awarding agency
Obligated
$124,710

Award facts

Contract value 100% obligated
$124,710.11 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6630 Chemical Analysis Instruments
Set-aside
No set-aside
Competition
Competed under SAP · 6 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Roche Diagnostics Corporation on July 17, 2026, for COBAS ASY Schedule 66 III clinical analyzers, with a ceiling value of $124,710.11. The call is issued under the Critical Analyzers, Laboratory schedule (FSS-66-III), a GSA Schedule vehicle. Performance occurs at Castleton, Indiana, and concludes September 30, 2026. The requirement is for fully automated clinical laboratory analyzer systems and related equipment to support medical treatment facility operations. The call carries a firm fixed price structure with no small-business set-aside.

Quick answers

Who was awarded contract HT009026FL046?

HT009026FL046 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on July 17, 2026.

How much is contract HT009026FL046 worth?

The government has obligated $124,710 on HT009026FL046.

Is contract HT009026FL046 an order under another contract?

Yes. HT009026FL046 is a BPA call under FA700025A0014, a blanket purchase agreement.

Was contract HT009026FL046 competed?

The extent of competition for HT009026FL046 was competed under sap. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award